February, 20th - 2 years ago
The report "PROTEOMICS MARKET”: By Technology (Chromatography, X-Ray Crystallography, Protein Microarray, Spectroscopy), By Services (Data Analysis & Maintenance, Quantitation Services, Analytical Laboratory Services) By Application (Drug Discovery, Clinical Diagnosis), By Geography (Asia Pacific, North America, Europe, Middle East And Africa, South America) - Forecast and Estimation (2018-2024). The global Proteomics market report is estimated to reach XX Billion by 2024 at a CAGR of XX%. Proteomics market share is likely to grow during the forecast period owing to the increase in cancer, diabetes, and demand for personalized medicines are the major factors driving the market. Global proteomics market segmented on the basis of services, technology, application, and geography. On the basis of service, the market is segmented into data analysis & maintenance, quantitation services, and analytical laboratory services. Data analysis and maintenance is anticipated to have the highest market growth among others due to the rise in bioinformatics databases and tools. Based on technology, the proteomics technologies are segmented into chromatography, X-ray Crystallography, protein microarray, spectroscopy, and others. Protein microarray is expected to have the highest share due to increase in research for diagnosis and treatment for chronic diseases. On basics of application, the proteomics market is categorized into drug delivery, clinical diagnosis, and others. Clinical diagnosis is expected to have a lucrative growth in size during the forecast period due to the increases in awareness on new diagnosis methodologies, usage of customized medicine, and emerging technologies in proteomics software market. The Asia Pacific is the fastest growing region due to increases in biosimilar market opportunities The Asia Pacific is projected to be the fastest-growing biosimilar market landscape during the forecast period 2018-2024. Key countries which are providing highest demand for proteomics in the Asia Pacific region are China, India, Japan, South Korea, and other economies because of huge investments in from both private and government for research and increase in demand for proteomics-based research to the Asia Pacific region are driving the market. The Proteomics market players include Celltrion Inc. (South Korea), Biocon Ltd. (India), Samsung Bioepis (South Korea), Pfizer Inc. (U.S.), and Teva Pharmaceuticals Industries Ltd. (Israel) among some other companies.